DuChemBio Co, LTD Q3 profit from the main business KRW 1.9 billion on sales of KRW 11.0 billion
AI summary · Not investment advice
Dukembio sold KRW 11.0 billion in Q3 and earned KRW 1.9 billion from its main business, down 0.2% from a year earlier and 1.8% from the prior quarter.
Operating profit · 3 months
KRW 1.9 billion
Key facts
- Revenue (3 months)
- KRW 11.0 billion
- Net income (3 months)
- KRW 1.5 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 9.9 billion
- Revenue (year to date)
- KRW 31.9 billion
- Operating profit (prior-year 3 months)
- KRW 1.9 billion
- Operating profit (year to date)
- KRW 5.1 billion
- Net income (prior-year 3 months)
- KRW 1.4 billion
- Net income (year to date)
- KRW 3.6 billion
Commentary
AI commentary · Not investment advice
What happened
Dukem Bio reported its consolidated results for the third quarter of 2026 in its quarterly report. Sales for the 3 months were KRW 11.02 billion. That is 11.1% more than the same 3 months a year earlier (KRW 9.93 billion) and 1.5% less than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 1.90 billion. It fell 0.2% from a year earlier (KRW 1.90 billion) and fell 1.8% from the previous quarter. Net income (final profit after taxes and other costs) for the 3 months was KRW 1.55 billion. It rose 7.7% from a year earlier (KRW 1.43 billion) and rose 28.3% from the previous quarter.
What changes for shareholders
For the year so far (January 1 to September 30), sales were KRW 31.92 billion. Operating profit was KRW 5.08 billion. Net income was KRW 3.62 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D